Lake Success, NYNCT07408089Now EnrollingIRB Ready

Breast Cancer Clinical Trial in Lake Success, NY

Access cutting-edge breast cancer treatment through this clinical trial at a research site in Lake Success. Study-provided care at no cost to qualified participants.

Sponsored by Boundless Bio, Inc.

Quick Self-Assessment

See if you qualify for this Lake Success location

Preparing your pre-screening questions…

Expert Care in Lake Success

Access breast cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related breast cancer treatment provided free

Apply for This Lake Success Location

Check if you qualify for this breast cancer clinical trial in Lake Success, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Lake Success

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Lake Success site if eligible
  4. 4Begin participation

About This Breast Cancer Study in Lake Success

This is a first-in-human, open-label, Phase 1 study evaluating BBI-940, an investigational kinesin oral molecular degrader, administered as monotherapy or in combination with fulvestrant in adults with advanced or metastatic breast cancer.

Sponsor: Boundless Bio, Inc.

Who Can Participate

Inclusion Criteria

Adults with locally advanced or metastatic breast cancer, including estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2-) disease or triple-negative breast cancer with luminal androgen receptor subtype (TNBC-LAR; androgen receptor expression ≥10% by immunohistochemistry), as applicable by study part.
Prior treatment with standard therapies known to provide clinical benefit, appropriate for disease subtype and study part, including endocrine therapy with CDK4/6 inhibition for ER+/HER2- disease.
Measurable disease per RECIST v1.1, except for participants enrolled in Part 1A.
Molecular eligibility as applicable by study part, including absence of an ESR1 mutation (Part 2A) or presence of FGFR1 amplification (Part 2B), based on prior local testing.
Availability of archival or newly obtained formalin-fixed, paraffin-embedded (FFPE) tumor tissue suitable for protocol-specified biomarker analyses.
Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
Adequate hematologic, hepatic, renal, and coagulation function per protocol-defined laboratory criteria.
Estimated life expectancy of at least 12 weeks.
Ability to swallow oral medication and provide written informed consent. Key

Exclusion Criteria

Prior exposure to an inhibitor or degrader of Kinesin.
Known hypersensitivity to study intervention(s) or excipients.
Receipt of recent anticancer therapy within protocol-defined washout periods.
Other active malignancy likely to interfere with study assessment.
Baseline QTcF \>470 msec or congenital long QT syndrome.
Clinically significant pulmonary embolism within 6 weeks prior to first dose.
Major surgery within 4 weeks or minor surgery within 2 weeks prior to first dose.
Active infection requiring systemic therapy within 2 weeks prior to first dose.
Pregnant or breastfeeding, or planning conception or gamete donation during the study or required post-treatment period.
Prior solid organ transplant or allogeneic stem cell transplant with protocol-defined exceptions.
Failure to recover to CTCAE Grade ≤1 (or baseline) from prior anticancer therapy, with protocol-specified exceptions.
Any serious or uncontrolled medical, laboratory, or psychiatric condition that could compromise safety or study integrity.
Other exclusion criteria as specified in the study protocol.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Lake Success?

Yes, this clinical trial (NCT07408089) has an active research site in Lake Success, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Breast Cancer Treatment Options in Lake Success, NY

If you're searching for breast cancer treatment options in Lake Success, NY, this clinical trial (NCT07408089) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Lake Success research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all breast cancer clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Lake Success, NY

See all breast cancer clinical trials recruiting in Lake Success — not just this study.

Browse Breast Cancer Trials in Lake Success →

Browse More Trials by Condition

Breast Cancer TrialsTriple Negative Breast Cancer TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Lake Success?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Lake Success, NY